Adjuvant systemic chemotherapy with or without hepatic arterial infusion of floxuridine in patients following colorectal cancer liver metastases resection (HARVEST): A prospective, randomized controlled trial.

被引：0
|
作者：
Li, Yu-Hong
Wang, De-Shen
Gu, Yang-Kui
Wen, Lei
Ren, Chao
Wu, Xiao-Jun
Yuan, Yun-Fei
Li, Bin-Kui
Zheng, Yun
Ding, Pei-Rong
Wang, Zhi-Qiang
Pan, Zhi-Zhong
Chen, Gong
Li, Li-Ren
Lu, Zhen-Hai
Tan, Qiong
Wan, De-Sen
Xu, Rui-Hua
机构：
[1] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Dept Minimally Invas Intervent Radiol, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Canc Ctr, Dept Med Oncol, Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ, Dept Colorectal Surg, Canc Ctr, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Dept Liver Surg, Canc Ctr, Guangzhou, Peoples R China
[6] Sun Yat Sen Univ, Dept Med Oncol, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3516
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of adjuvant FOLFOX/FOLFIRI with versus without hepatic arterial infusion of floxuridine in patients following colorectal cancer liver metastasectomy (HARVEST trial): A randomized controlled trial
    Wang, De-Shen
    Fong, William Pat
    Wen, Lei
    Cai, Yan-Yu
    Ren, Chao
    Wu, Xiao-Jun
    Zhang, Tian-Qi
    Cao, Fei
    Zuo, Meng-Xuan
    Li, Bin-Kui
    Zheng, Yun
    Li, Li-Ren
    Chen, Gong
    Ding, Pei-Rong
    Lu, Zhen-Hai
    Zhang, Rong-Xin
    Yuan, Yun-Fei
    Pan, Zhi-Zhong
    Li, Yu-Hong
    EUROPEAN JOURNAL OF CANCER, 2025, 214
  • [2] Systemic exposure of floxuridine after hepatic arterial infusion pump chemotherapy with floxuridine in patients with resected colorectal liver metastases
    IJzerman, Nikki S.
    Filipe, Wills F.
    de Bruijn, Peter
    Buisman, Florian E.
    van Doorn, Leni
    Doornebosch, Pascal G.
    Holster, Jessica J.
    Grootscholten, Cecile
    Gruenhagen, Dirk J.
    van Bommel, Christian P. E.
    Homs, Marjolein Y. V.
    Kok, Niels F. M.
    Verhoef, Cornelis
    Koerkamp, Bas Groot
    Kuhlmann, Koert F. D.
    Mathijssen, Ron H. J.
    Koolen, Stijn L. W.
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 162
  • [3] Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Hepatic Metastases From Colorectal Cancer
    Kemeny, Nancy E.
    Jarnagin, William R.
    Capanu, Marinela
    Fong, Yuman
    Gewirtz, Alexandra N.
    DeMatteo, Ronald P.
    D'Angelica, Michael I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07) : 884 - 889
  • [4] A randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer
    Kemeny, N. E.
    Jarnagin, W. R.
    Capanu, M.
    Fong, Y.
    Gewirtz, A.
    DeMatteo, R. P.
    D'Angelica, M. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] ADJUVANT HEPATIC ARTERIAL INFUSION CHEMOTHERAPY AFTER CURATIVE RESECTION OF COLORECTAL LIVER METASTASES
    CURLEY, SA
    ROH, MS
    CHASE, JL
    HOHN, DC
    AMERICAN JOURNAL OF SURGERY, 1993, 166 (06): : 743 - 748
  • [6] Feasibility of Adjuvant Hepatic Arterial Infusion of Chemotherapy After Radiofrequency Ablation With or Without Resection in Patients With Hepatic Metastases From Colorectal Cancer
    Courtney L. Scaife
    Steven A. Curley
    Francesco Izzo
    Paolo Marra
    Paolo Delrio
    Bruno Daniele
    Franco Cremona
    Jeffrey E. Gershenwald
    Judy L. Chase
    Richard D. Lozano
    Yehuda Z. Patt
    Bruno D. Fornage
    Jean Nicolas Vauthey
    Misty L. Woodall
    Karen B. Gonzalez
    Lee M. Ellis
    Annals of Surgical Oncology, 2003, 10 : 348 - 354
  • [7] Prospective randomised trial on adjuvant hepatic artery infusion chemotherapy after RO resection of colorectal liver metastases
    Rudroff, C
    Altendorf-Hoffmann, A
    Stangl, R
    Scheele, J
    LANGENBECKS ARCHIVES OF SURGERY, 1999, 384 (03) : 243 - 249
  • [8] Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer
    Scaife, CL
    Curley, SA
    Izzo, F
    Marra, P
    Delrio, P
    Daniele, B
    Cremona, F
    Gershenwald, JE
    Chase, JL
    Lozano, RD
    Patt, YZ
    Fornage, BD
    Vauthey, JN
    Woodall, ML
    Gonzalez, KB
    Ellis, LM
    ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (04) : 348 - 354
  • [9] Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases – the multicenter randomized controlled PUMP trial
    F. E. Buisman
    M. Y. V. Homs
    D. J. Grünhagen
    W. F. Filipe
    R. J. Bennink
    M. G. H. Besselink
    I. H. M. Borel Rinkes
    R. C. G. Bruijnen
    A. Cercek
    M. I. D’Angelica
    O. M. van Delden
    M. L. Donswijk
    L. van Doorn
    P. G. Doornebosch
    J. Emmering
    J. I. Erdmann
    N. S. IJzerman
    C. Grootscholten
    J. Hagendoorn
    N. E. Kemeny
    T. P. Kingham
    E. G. Klompenhouwer
    N. F. M. Kok
    S. Koolen
    K. F. D. Kuhlmann
    M. C. Kuiper
    M. G. E. Lam
    R. H. J. Mathijssen
    A. Moelker
    E. Oomen-de Hoop
    C. J. A. Punt
    W. W. te Riele
    J. M. L. Roodhart
    R. J. Swijnenburg
    W. Prevoo
    P. J. Tanis
    M. Vermaas
    M. W. J. Versleijen
    F. P. Veuger
    M. J. Weterman
    C. Verhoef
    B. Groot Koerkamp
    BMC Cancer, 19
  • [10] Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial
    Buisman, F. E.
    Homs, M. Y. V.
    Grunhagen, D. J.
    Filipe, W. F.
    Bennink, R. J.
    Besselink, M. G. H.
    Rinkes, I. H. M. Borel
    Bruijnen, R. C. G.
    Cercek, A.
    D'Angelica, M. I.
    van Delden, O. M.
    Donswijk, M. L.
    van Doorn, L.
    Doornebosch, P. G.
    Emmering, J.
    Erdmann, J. I.
    IJzerman, N. S.
    Grootscholten, C.
    Hagendoorn, J.
    Kemeny, N. E.
    Kingham, T. P.
    Klompenhouwer, E. G.
    Kok, N. F. M.
    Koolen, S.
    Kuhlmann, K. F. D.
    Kuiper, M. C.
    Lam, M. G. E.
    Mathijssen, R. H. J.
    Moelker, A.
    Oomen-de Hoop, E.
    Punt, C. J. A.
    Riele, W. W. te
    Roodhart, J. M. L.
    Swijnenburg, R. J.
    Prevoo, W.
    Tanis, P. J.
    Vermaas, M.
    Versleijen, M. W. J.
    Veuger, F. P.
    Weterman, M. J.
    Verhoef, C.
    Koerkamp, B. Groot
    BMC CANCER, 2019, 19 (1)
12345